← All stocks

BIOVIE INC.

BIVI Net buying
CIK 0001580149 #5165 in the set updated 17 Sep 2026
Bought (120 mo)
$513.14K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$352.70K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$352.70K
8 of 8 sales
Net
+$160.43K
+$160.43K against sales at will

By person

18 insiders · 28 transactions
20.9×

Cuong Do holds 20.9 times base salary in stock. $12.94M of shares against $618.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Cuong Do last reported holding, valued at $2.18, the price Common Stock was last bought or sold at on the open market here, on 28 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
GORLIN STEVE
Director
$435.42K (11)
$154.01K (2)
+$281.41K
111,558
$243.20K
+59.1%
BERMAN RICHARD J
Director
$198.70K (6)
−$198.70K
40,643
$88.60K
DO CUONG V
President & CEO
$49.44K (4)
+$49.44K
5,935,484
$12.94M
+22.7%
KIM JOANNE WENDY
Chief Financial Officer
$16.25K (2)
+$16.25K
5,441
$11.86K
Palumbo Joseph M
Chief Medical Officer
$10.46K (1)
+$10.46K
6,036
$13.16K
Chappell Amy Suzon
Director
$1.57K (1)
+$1.57K
727
$1.58K
PEIZER TERREN S
Director
27,425,166
$59.79M
+543.9%
Sooch Mina
Director
813,636
$1.77M
+208.6%
Kumar Hari
Director
727,272
$1.59M
+433.3%
Sherman Michael Edward
Director
718,181
$1.57M
+1,294%
Anderson Julie G
Director
368,500
$803.33K
+268.5%
Lang James Paul
Director
68,622
$149.60K
Adams Jonathan M
EVP Liver Cirrhosis Programs
48,630
$106.01K
MARKHAM PENELOPE
EVP Liver Cirrhosis R&D
47,841
$104.29K
+347.4%
Hariri Robert J
Director
42,254
$92.11K
Ahlem Clarence N.
EVP Neuroscience Product Dev.
37,148
$80.98K
READING CHRISTOPHER
EVP Neuroscience R&D
37,148
$80.98K
ROGICH SIGMUND
Director
36,926
$80.50K

No percentages here. This company's share count has moved by a factor of 2.5 over the window, from 7,540,316 to 18,562,376 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
PEIZER TERREN S
22 Sep 2020
Director
Exercised, kept indirect
1,549,750
$0.00
$154.98

What was left out

Form 4 filings counted 113
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 8
Transactions with no price 2
Shares from compensation/vesting 28,447,683
History held since 1 Aug 2018